Aaron Rosenberg, Chief Financial Officer at BeOne Medicines Ltd. (ONC), sold 1,157 shares at $312.71 ($362K) on 2026-08-03, disclosed to the SEC on 2026-08-05.
Open-market sale of $362k ONC by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |